Metabolic Syndrome: The Warning Signs Your Body May Be Sending

Five Connected Risk Factors That Can Affect Your Entire Health

Metabolic syndrome is not one single disease. It is a cluster of related health conditions that occur together and significantly increase the risk of developing:

  • Type 2 diabetes
  • Heart disease
  • Heart attack
  • Stroke
  • Kidney disease
  • Fatty liver disease
  • Circulation problems
  • Other serious metabolic complications

A person is generally diagnosed with metabolic syndrome when they have at least three of five major risk factors: elevated blood sugar, high blood pressure, high triglycerides, low HDL cholesterol, and excess abdominal weight. (National Heart, Lung, and Blood Institute)

The earlier these warning signs are identified, the sooner patients can begin addressing the underlying metabolic dysfunction.

What Is Metabolic Syndrome?

Metabolic syndrome develops when several interconnected problems begin affecting how the body processes energy, regulates blood sugar, stores fat, and maintains healthy blood pressure and cholesterol levels. Insulin resistance often plays a central role.

Insulin is a hormone that helps move glucose from the bloodstream into the body’s cells, where it can be used for energy. When the cells stop responding properly to insulin, the pancreas must produce increasing amounts of insulin to keep blood sugar controlled. This condition is known as insulin resistance.

Over time, insulin resistance may contribute to:

  • Elevated blood sugar
  • Increased abdominal fat
  • High triglycerides
  • Low HDL cholesterol
  • Elevated blood pressure
  • Prediabetes
  • Type 2 diabetes

Insulin resistance can be present for years before diabetes is diagnosed. (NIDDK)

The Five Signs of Metabolic Syndrome

Metabolic syndrome is typically diagnosed when a patient has three or more of the following conditions.

Fat stored around the abdomen is more metabolically active than fat stored in other areas of the body. It is strongly associated with insulin resistance, inflammation, abnormal cholesterol levels, and cardiovascular risk.

Common waist-circumference thresholds used when evaluating metabolic syndrome are:

Men: Greater than 40 inches
Women: Greater than 35 inches

Appropriate thresholds may differ depending on ethnicity, body composition, and the clinical guideline being used. (www.heart.org)

Elevated fasting glucose may indicate that the body is becoming resistant to insulin or that the pancreas is struggling to keep up with the body’s insulin needs.

A patient may have:

  • Insulin resistance
  • Elevated fasting glucose
  • Prediabetes
  • Type 2 diabetes
  • High insulin levels despite a glucose result that appears relatively normal

This is one reason MCE may evaluate the patient’s broader metabolic picture rather than relying on only one blood sugar result.

Triglycerides are a type of fat found in the blood. Elevated triglycerides may be associated with:

  • Excess intake of refined carbohydrates
  • Insulin resistance
  • Excess abdominal weight
  • Poorly controlled diabetes
  • Fatty liver disease
  • Certain medications
  • Alcohol intake
  • Genetic factors

A triglyceride level of 150 mg/dL or higher—or treatment for elevated triglycerides—is one of the commonly used metabolic syndrome criteria. (www.heart.org)

HDL is commonly referred to as “good” cholesterol because it helps transport cholesterol away from the arteries.

Low HDL is generally defined as:

Men: Less than 40 mg/dL
Women: Less than 50 mg/dL

Low HDL may occur alongside high triglycerides, inactivity, smoking, excess abdominal weight, and insulin resistance. (www.heart.org)

High blood pressure places additional strain on the heart, arteries, kidneys, and other organs.

Insulin resistance, excess weight, inflammation, genetics, stress, sleep disorders, kidney disease, and dietary factors may all contribute to elevated blood pressure.

Because high blood pressure often causes no noticeable symptoms, routine measurement is essential.

What Are the Symptoms of Metabolic Syndrome?

Metabolic syndrome is often described as a silent condition because many people experience few or no obvious symptoms. A patient may feel relatively well while elevated blood sugar, blood pressure, triglycerides, and insulin resistance are gradually affecting the body.

Possible symptoms or warning signs may include:

Energy & Weight

Blood Sugar Signals

Sleep & Cognitive

Skin, Nerve & Vascular

High blood sugar may cause increased thirst, frequent urination, blurred vision, weakness, and fatigue, but many of the individual components of metabolic syndrome produce no noticeable symptoms. (NHLBI, NIH)

These symptoms can have many different causes. Laboratory testing and a medical evaluation are necessary to determine whether metabolic syndrome or another health condition is present.

Why Traditional Care May Not Be Enough

Many patients are treated separately for high blood pressure, elevated cholesterol, weight gain, or blood sugar without understanding how these conditions are connected.

"One medication for blood pressure..."

"Another medication for cholesterol..."

"Another medication for glucose..."

"General advice to lose weight..."

"Return for laboratory testing later..."

These treatments may be necessary, but some patients need a more coordinated plan that addresses the underlying metabolic pattern.

At Metabolic Centers for Excellence, we look at how blood sugar, insulin resistance, nutrition, weight, circulation, nerve health, medications, and lifestyle factors may be affecting one another.

How MCE Can Make a Difference

MCE provides a comprehensive, individualized approach for patients with metabolic syndrome, insulin resistance, prediabetes, type 2 diabetes, and related complications. Our goal is not simply to focus on one abnormal number. We evaluate the broader metabolic picture and help patients understand what may be driving their health concerns.

Comprehensive Metabolic Evaluation​

Depending on the patient, MCE may evaluate:

Depending on the patient, MCE may evaluate:

A1C | Fasting glucose | Glucose patterns | Indicators of insulin resistance | Cholesterol and triglycerides | Blood pressure | Weight and body composition | Waist circumference | Kidney and liver function | Nutrition habits | Physical activity | Sleep patterns | Current medications | Neuropathy symptoms | Circulation concerns | Other metabolic complication

Addressing Insulin Resistance at Its Source

Insulin resistance is often the earliest sign of metabolic syndrome.

A normal glucose or A1C doesn’t always tell the full story. The pancreas may be producing elevated amounts of insulin to compensate.

By examining the patient’s complete metabolic profile, MCE may be able to identify concerns earlier and develop a more focused treatment plan.

Individualized Treatment Planning

MCE may develop a plan that includes:

Depending on the patient, MCE may evaluate:

Nutrition education | Anti-inflammatory food guidance | Physical activity recommendations | Medical weight-management support | Medication review | Blood-glucose monitoring | Follow-up laboratory testing | Neuropathy evaluation | Cardiovascular and kidney-risk review | Coordination with the patient’s other healthcare providers

MCE's
MIT Program for Eligible Patients

MCE offers a medically supervised Metabolic Infusion Treatment program, or MIT, for appropriately selected patients. MIT uses carefully controlled, small-dose insulin hormone administration combined with glucose monitoring and clinical supervision. It may be incorporated into a broader metabolic care plan that also includes nutrition, activity, medication review, laboratory monitoring, and management of related health risks.

Depending on the patient, the MCE MIT program may include:
  • Provider evaluation
  • Metabolic laboratory testing
  • Review of glucose patterns
  • Supervised treatment sessions
  • Blood-glucose monitoring during treatment
  • Nutrition and lifestyle guidance
  • Medication review
  • Progress assessments
  • Follow-up laboratory testing
  • Monitoring for diabetes-related complications
  • Coordination with other treating providers

MIT is not considered a standard first-line treatment for metabolic syndrome and is not appropriate for every patient. A provider must determine whether it may be considered based on the patient’s diagnosis, glucose levels, insulin use, medications, medical history, and overall clinical risk. MIT should be presented as one component of a comprehensive, medically supervised treatment plan—not as a replacement for healthy nutrition, physical activity, prescribed medication, or specialty care.

Do Not Wait for Metabolic Syndrome to Progress!

Metabolic syndrome is a serious warning that the body is struggling to properly regulate blood sugar, blood pressure, fat storage, and cholesterol.

Take the first step toward understanding your blood sugar, insulin resistance, cardiovascular risks, and long-term metabolic health.

Frequently Asked Questions

Metabolic syndrome can affect people of different ages and body types. Although excess abdominal weight is a common risk factor, a person does not have to appear significantly overweight to have insulin resistance or poor metabolic health. (CDC)

Risk may be higher among people with:

  • Prediabetes
  • Type 2 diabetes
  • A family history of diabetes
  • Excess abdominal weight
  • A sedentary lifestyle
  • High blood pressure
  • High triglycerides
  • Low HDL cholesterol
  • Polycystic ovary syndrome
  • A history of gestational diabetes
  • Fatty liver disease
  • Sleep apnea
  • Kidney disease
  • Chronic stress
  • Poor sleep habits
  • A diet high in refined carbohydrates or added sugar
  • Certain hormonal conditions
  • Certain medications
  • A history of smoking

Women with PCOS frequently have insulin resistance, which increases their risk of developing type 2 diabetes and related metabolic conditions. (CDC)

Metabolic syndrome is not diagnosed by one test alone.

A healthcare provider may evaluate:

  • Waist circumference
  • Blood pressure
  • Fasting blood glucose
  • A1C
  • Triglycerides
  • HDL and LDL cholesterol
  • Weight and body composition
  • Medical and family history
  • Current medications
  • Nutrition and physical activity

Additional testing may be appropriate depending on the patient’s symptoms and medical history.

This may include:

  • Fasting insulin
  • Kidney-function testing
  • Liver-function testing
  • Urine protein screening
  • Thyroid testing
  • Hormone evaluation
  • Screening for fatty liver disease
  • Sleep apnea screening
  • Cardiovascular-risk assessment

Standard diagnostic evaluation includes measuring blood pressure and obtaining blood tests for glucose, cholesterol, and triglyceride levels. (NHLBI, NIH)

There is no single medication that treats every part of metabolic syndrome. Treatment typically focuses on improving lifestyle habits and addressing each individual risk factor.

Heart-healthy lifestyle changes are considered the first line of treatment. Medication or, in some cases, metabolic surgery may be considered when lifestyle intervention alone is not sufficient. (NHLBI, NIH)

Typically, treatment targets these areas:

  • Nutrition
  • Physical Activity
  • Weight Management
  • Blood Sugar Treatment
  • Cholesterol and Triglyceride Treatment
  • Sleep and Stress Management
  • Smoking Cessation

Each component of metabolic syndrome carries its own health risks. When several occur together, they may reinforce one another and increase the likelihood of chronic disease.

Untreated metabolic syndrome may contribute to:

Type 2 Diabetes
Heart Disease and Stroke
Fatty Liver Disease
Kidney Disease
Neuropathy and Circulation Problems
Chronic Inflammation

Medical Disclaimer

This webpage is intended for general educational purposes only and does not replace individualized medical advice, diagnosis, emergency care, or treatment.

Metabolic syndrome requires an individualized treatment plan based on the patient’s health history, examination, laboratory findings, medications, and risk factors. Patients should not stop, reduce, or change prescribed medication or insulin without direction from the prescribing healthcare provider.

MIT is a medically supervised treatment available only to appropriately selected patients following a clinical evaluation. Individual responses and outcomes vary.